Mesenchymal Stem Cells in Chronic Wounds: The Spectrum from Basic to Advanced Therapy

Area of Science:

• Regenerative Medicine
• Wound Healing Research
• Biomedical Engineering

Background:

• Chronic cutaneous wounds affect millions, with increasing prevalence due to aging, diabetes, and cardiovascular disease.
• Current treatments, including growth factors and skin substitutes, show limited efficacy, with only 50-60% complete closure and high recurrence rates.
• Advanced therapeutic strategies are crucial for managing nonhealing wounds effectively.

Approach:

• Investigating mesenchymal stem cells (MSCs) for wound healing due to their differentiation potential, immunomodulatory properties, and paracrine effects.
• Evaluating MSC-mediated mechanisms including inflammation reduction, enhanced angiogenesis, and minimized scarring.
• Addressing limitations such as cell delivery, viability, preparation heterogeneity, and wound bed preparation.

Key Points:

• Mesenchymal stem cells (MSCs) accelerate wound healing by modulating the inflammatory response.
• MSCs promote angiogenesis and reduce scar formation, contributing to improved tissue regeneration.
• Challenges remain in optimizing MSC delivery, ensuring cell viability, and standardizing preparations.

Conclusions:

• Mesenchymal stem cells (MSCs) offer a promising therapeutic avenue for chronic wound management.
• Further large-scale, controlled clinical trials are essential to establish MSC safety and efficacy.
• Overcoming current limitations will pave the way for broader clinical application of MSC-based therapies.